Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis
F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG
PET/CT) is a robust imaging modality used for staging multiple myeloma (MM) and …
PET/CT) is a robust imaging modality used for staging multiple myeloma (MM) and …
[HTML][HTML] Bone marrow segmentation and radiomics analysis of [18F] FDG PET/CT images for measurable residual disease assessment in multiple myeloma
E Milara, A Gómez-Grande, S Tomás-Soler… - Computer Methods and …, 2022 - Elsevier
Background and objectives The last few years have been crucial in defining the most
appropriate way to quantitatively assess [18 F] FDG PET images in Multiple Myeloma (MM) …
appropriate way to quantitatively assess [18 F] FDG PET images in Multiple Myeloma (MM) …
Machine Learning Model Based on Optimized Radiomics Feature from 18F-FDG-PET/CT and Clinical Characteristics Predicts Prognosis of Multiple Myeloma: A …
B Ni, G Huang, H Huang, T Wang, X Han… - Journal of Clinical …, 2023 - mdpi.com
Objects: To evaluate the prognostic value of radiomics features extracted from 18F-FDG-
PET/CT images and integrated with clinical characteristics and conventional PET/CT metrics …
PET/CT images and integrated with clinical characteristics and conventional PET/CT metrics …
Leveraging RSF and PET images for prognosis of multiple myeloma at diagnosis
L Morvan, T Carlier, B Jamet, C Bailly… - International journal of …, 2020 - Springer
Purpose Multiple myeloma (MM) is a bone marrow cancer that accounts for 10% of all
hematological malignancies. It has been reported that FDG PET imaging provides …
hematological malignancies. It has been reported that FDG PET imaging provides …
18F‑FDG PET/CT based radiomics features improve prediction of prognosis: multiple machine learning algorithms and multimodality applications for multiple …
H Zhong, D Huang, J Wu, X Chen, Y Chen… - BMC Medical Imaging, 2023 - Springer
Purpose Multiple myeloma (MM), the second most hematological malignancy, have been
studied extensively in the prognosis of the clinical parameters, however there are only a few …
studied extensively in the prognosis of the clinical parameters, however there are only a few …
Artificial intelligence–based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma
Purpose Multiple myeloma (MM) is a highly heterogeneous disease with wide variations in
patient outcome.[18F] FDG PET/CT can provide prognostic information in MM, but it is …
patient outcome.[18F] FDG PET/CT can provide prognostic information in MM, but it is …
Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myeloma
Abstract Purpose [18F] FDG PET/CT is an imaging modality of high performance in multiple
myeloma (MM). Nevertheless, the inter-observer reproducibility in PET/CT scan …
myeloma (MM). Nevertheless, the inter-observer reproducibility in PET/CT scan …
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two …
B Jamet, L Morvan, C Nanni, AV Michaud… - European journal of …, 2021 - Springer
Purpose Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-
PET/CT) is included in the International Myeloma Working Group (IMWG) imaging …
PET/CT) is included in the International Myeloma Working Group (IMWG) imaging …
Pretreatment 18F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple …
Y Abe, K Narita, H Kobayashi, A Kitadate… - European journal of …, 2019 - Springer
Abstract Purpose Both 18 F-FDG PET/CT and clonal circulating plasma cell (CPC)
quantification are emerging tools for multiple myeloma (MM) prognostication that have been …
quantification are emerging tools for multiple myeloma (MM) prognostication that have been …
Molecular signature of 18F-FDG PET biomarkers in newly diagnosed multiple myeloma patients: a genome-wide transcriptome analysis from the CASSIOPET study
JB Alberge, F Kraeber-Bodéré, B Jamet… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The International Myeloma Working Group recently fully incorporated 18F-FDG PET into
multiple myeloma (MM) diagnosis and response evaluation. Moreover, a few studies …
multiple myeloma (MM) diagnosis and response evaluation. Moreover, a few studies …
相关搜索
- cluster analysis myeloma patients
- poor prognosis myeloma patients
- cluster analysis poor prognosis
- pet biomarkers myeloma patients
- fdg pet myeloma outcome
- fdg pet combined analysis
- fdg pet survival forest
- prediction of prognosis radiomics features
- myeloma outcome combined analysis
- molecular signature myeloma patients
- transcriptome analysis pet biomarkers
- fdg pet clinical characteristics
- transcriptome analysis myeloma patients